This study, a retrospective chart review of 82 consecutive male
inpatients, assessed the spectrum and prevalence of neuroleptic malignant
syndrome. The prevalence of diagnosed neuroleptic malignant syndrome (2.4%)
was greater than that generally reported. Eight additional patients
manifested symptoms that abated without cessation of neuroleptic treatment.
This suggests that neuroleptic malignant syndrome is a spectrum disorder
that has milder variants. Affective illness may be a risk factor for its
development.Abstract Teaser